FDA approves Avadel Pharmaceuticals' once-nightly dosing sleep disorder drug, Lumryz, for children aged 7 years and older, offering a new option for narcolepsy treatment.
Study uncovers the crucial role of protein turnover in influenza A virus replication, identifying potential antiviral targets in the host’s cellular machinery.
A large retrospective study of over 600,000 pediatric patients found children diagnosed with COVID-19 had a 58% higher risk of developing type 2 diabetes within 6 months compared to those with other respiratory infections.
In a phase 3 trial, 67% of children treated with omalizumab tolerated 600 mg of peanut protein, a dramatic increase over just 7% with placebo, highlighting omalizumab’s potential in managing pediatric food allergies.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A consensus panel of medical education experts identified 36 nutrition competencies recommended for inclusion in undergraduate and graduate medical education curricula in the U.S.
The World Health Organization recommends maternal vaccination and antibody therapy for preventing respiratory syncytial virus (RSV) in infants, with concerns raised around supply and treatment equity.
Eighty FCCs had properties that warrant further investigation for potential health concerns, such as carcinogenic, mutagenic, and reproductive toxicity.
From overflowing cribs to empty pediatric wings, new data reveals a 133.3% difference in children's hospital bed occupancy rates between the most and least crowded states.